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Within the last several years, murine B cells have been classified into subsets 
that differ with respect to surface marker phenotype, tissue distribution, and/or 
functional responsiveness to a variety of T-dependent and T-independent anti- 
gens (1-8).  In  general,  these  subsets  have been  considered representative of 
different developmental stages of a  single B cell lineage; however, arguments 
have also been advanced for separate lineages (5, 7, 8). This report demonstrates 
that one such subset, Ly-1  B, has the properties of a  distinct lineage in that it 
fails to develop from the bone marrow-based progenitors that give rise to other 
B ceils in irradiated recipients. 
Ly-1 B cells carry the Ly-1  surface antigen in conjunction with IgM, IgD, Ia, 
and other typical B cell surface markers (9). They are distinguishable from the 
predominant  B  cell  populations  in  spleen  and  lymph  nodes  by  a  variety of 
characteristics, e.g, low levels of surface IgD, high levels of surface IgM, presence 
in spleen but not lymph node, predominance in peritoneal populations, increased 
frequency in NZB-related mice, and decreased frequency in SJL mice (9,  10). In 
addition, they are  functionally distinct from other  B  cells  in  that they rarely 
participate in  IgM antibody responses to exogenous (laboratory) antigens and 
frequently contribute  to  IgM  autoantibody production in  normal and  (NZB- 
related) autoimmune mice (1 1). 
Ly-1  is not simply a  B cell "activation" marker, since it is not detectable on 
mitogen-stimulated B  cell  "blasts" activated in  vitro  or  on  antigen-stimulated 
germinal center cells  and antibody-producing ceils activated in vivo (1 1).  Fur- 
thermore, it is not a  maturation marker, since it is present both on immature 
and  mature  cell  types,  e.g.,  on  pre-B  tumor  cells and  on  normal  B  cells  in 
neonates, as well as on antibody-secreting tumor lines and autoantibody-secreting 
splenic and peritoneal cells in adult animals. This evidence, which indicates that 
the Ly-l-bearing B cell subset contains cells at different stages of maturation and 
activation, suggests that this subset represents a distinct B cell lineage. 
Data from cell transfer studies presented here support this hypothesis. In these 
precursor/progeny experiments, we compare cell populations from various do- 
nor organs for their ability to reconstitute particular B cell  subsets when trans- 
ferred  to  lethally irradiated  allotype-congenic recipients.  On  the  whole,  our 
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results are consistent with previous evidence (12-16) demonstrating that progen- 
itors present in newborn liver and in spleen and bone marrow from mice of all 
ages reconstitute B cells in these recipients. Surprisingly, however, we find that 
adult bone marrow and spleen specifically lack the ability to reconstitute Ly-1 B 
cells. Since our studies also demonstrate that Lyol B cells are readily reconstituted 
by progenitors from other sources (e.g.,  newborn liver, adult peritoneum), we 
interpret  our  findings  as  favoring  the  existence of separate  progenitors  (and 
hence separate lineages) for Ly-1 B and for other B cells. 
Materials and  Methods 
Mice.  BALB/cN, BAB/14 mice were raised in our breeding colony. CBA mice con- 
genic for Ig allotype (CBA-Igh  b) were established by Dr.  H. S.  Micklem (Immunology 
Unit, University of Edinburgh, Edinburgh, Scotland) and were his generous gift. CBA/ 
HN mice were also obtained from Dr. Micklem and bred in our animal facility. 3-mo-old 
female or male mice were used in most experiments as adult donors except in certain 
experiments described below. 4-6-mo-old mice were used as irradiated recipients. 
Preparation  of Cells.  Femur and  tibia  were  used as  sources of bone marrow cells. 
Peritoneal washout cells (PerC)  ~ were obtained by injecting 8-10 ml of chilled medium 
(RPMI 1640; Irvine Scientific, Santa Ana, CA) containing 3% newborn calf serum (NCS) 
into the peritoneal cavity of mice. 90% of the injected volume was usually recovered by 
this procedure. Cells were passed through nylon mesh and washed twice with 3% NCS- 
RPMI. 
Radiation and Transfer.  Mice were irradiated with 600 rad by x-ray 1 d before transfer. 
Cells were resuspended in serum-free medium, and 107 cells were injected intravenously 
into the irradiated mice. 
Antibodies  and Reagents.  Anti-Igh-6b (IgM  b, AF6-78.25) and anti-Igh-Sb(IgD  b, AF6- 
122.2) were made by Dr. A.  Stall (Becton, Dickinson & Co.,  Mountain View,  CA) as 
described elsewhere (17).  Anti-Igh-6b,  anti-Igh5b,  and anti-Igh-Sa  (10-4.2) (18)  were 
purified from mice ascites. Rat monocional antibodies anti-IgM (331.12) (19), anti-Ly-1 
(53-7.3) (20), and anti-Lyt-2 (53-6.7) (20) were purified from supernatant obtained by 
culture in serum-free medium (HB101; Hana Media, Inc., Berkeley, CA) (21). Avidin was 
purchased from Vector Laboratories, Inc. (Burlingame, CA). The methods for Texas Red 
(Molecular Probes, Inc., Junction City, OR) conjugation to avidin and for biotination or 
fluoresceination of antibodies have been described previously (9). 
Anti-Ly-1 and anti-Lyt-2 antibodies were used as F(ab')~ reagents to avoid labeling Fc- 
binding cells. Both antibodies are rat IgG2a, whose chemical characteristics are similar to 
mouse IgG1  (crossreactive with anti-mouse IgG1). After digestion of antibody with 5% 
pepsin  in  0.1  M  sodium acetate buffer (pH  4.5)  at  37°C  for  12  h,  the  mixture was 
fractionated on an AcA 44 (LKB Instruments, Inc., Gaithersburg, MD) column (22). The 
fractions that do not bind anti-mouse  IgG1  but still  show specific cell-binding activity 
were pooled and used for biotination. 
Staining Procedure  and Data Analysis.  Erythrocytes in spleen cells were depleted by 
treatment with 0.165 M NH4CI.  PerC were prepared as described above. The two-color 
staining procedure and data analysis by modified fluorescence-activated  cell sorter (FACS 
II; Becton-Dickinson Immunocytometry Systems, Inc.,  Mountain View, CA) and VAX 
computer have been described previously (9).  An  extra channel was  added  to detect 
scattered light from cells at large angles (obtuse scatter), which was particularly useful for 
peritoneal cell analysis.  Since cells that scatter a large amount of light to the obtuse scatter 
photodetector are mostly granulocytes, monocytes, polymorphonuclear cells,  or other 
nonlymphoid cells (23), these cells (15-40% in PerC from the irradiated reconstituted 
mice) were gated out in the analysis of the lymphocyte population. 
1Abbreviations used in  this paper:  BrMRBC, bromelain-treated  mouse red blood cell; FACS, 
fluorescence-activated cell sorter; NCS, newborn calf serum; PerC, peritoneal "wash-out" cell; PFC, 
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Inhibition ofAnti-BrMRBC PFC.  B 10 mice were used as the source of mouse red blood 
cells (MRBC). The bromelain (Br) treatment of MRBC and the plaque-forming cell (PFC) 
procedure were described previously (11). 30 #g of anti-Igh-6b antibody (IgG1 anti-IgM) 
was used to inhibit the generation of anti-BrMRBC PFC from 2 ×  107 spleen cells (24). 
Results 
Bone Marrow Cells from Adult Animals Contain Progenitors  That Reconstitute Most 
of the B Cells in Spleen.  Virtually all B cells in lethally irradiated mice reconsti- 
tuted  with  allotype-congenic, bone  marrow  cells  are  derived  from  the  donor 
inoculum.  These  B  cells  carry  donor  (rather  than  recipient)  IgD  and  IgM 
allotypes,  and  are  therefore  specifically  recognizable  in  FACS analyses  with 
monoclonal antibody reagents that detect surface Ig allotypes. Thus, for example, 
B  cells in  600  rad-irradiated  BALB/c (Igh') mice reconstituted with  BAB/14 
(Igh  b) bone marrow are marked with the Igh-5b (IgD) and Igh-6b (IgM) aliotypes, 
which are expressed on the BAB/14 (Igh  b) donor B cells (see Fig.  1). 
The  frequencies of donor-derived  B  cells  in reconstituted recipients  rise  to 
nearly normal  levels by  1  mo after transfer and  stabilize at somewhat higher 
(effectively normal) frequencies shortly thereafter. Surface IgM a93 IgD expres- 
sion patterns shift during this reconstitution period. Initially, the IgM/IgD FACS 
contour  plots  resemble  plots  obtained  with  cells  from  very  young  animals. 
However,  by  1  mo  after  transfer,  the  reconstituted  B  cells  have  established 
overall patterns of surface IgD and IgM expression that are almost indistinguish- 
able from the patterns displayed by B cells in the same locations in normal adult 
(nonirradiated) animals; e.g., compare IgM/IgD FACS contour plots for spleen 
cells in Figs.  1 and 2.  Thus, adult bone marrow transfers are clearly capable of 
restoring most of the B cells normally found in spleen and lymph nodes. 
Bone marrow transfers do not, however, restore all B cells. As we will show, 2 
mo after transfer, animals reconstituted with bone marrow still lack significant 
numbers of donor-derived Ly-1 B cells. The FACS analysis of splenic and lymph 
node B cells discussed above  largely failed to reveal this deficit because lymph 
nodes  almost  never  contain 
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FIGURE  1.  Bone  marrow transfers reconstitute most splenic B cells. BAB/14 (Igh  b) bone 
marrow cells from 12-wk-old (adult) animals were transferred to 600-rad irradiated BALB/c 
(lgh') mice. Mice were killed 11, 28 (1 too), and 56 d (2 too) after transfer, and were analyzed 
for donor-derived B cells by simultaneous staining with fluoresceinated  anti-Igh6  b and biotin- 
ated anti-lgh5  b antibodies that detect donor allotypic  determinants. HAYAKAWA ET AL.  1557 
usually contain so few Ly-1 B that frequency reductions are difficult to document, 
particularly in animals that have a reasonable number of B cells with the same 
bright IgM, dull IgD phenotype as Ly-1  B. 
On the other hand, the Ly-1  B deficit in irradiated recipients of adult bone 
marrow is readily demonstrated by functional studies that detect autoantibody 
production by splenic Ly-1 B cells (see below). Furthermore, it is clearly visible 
in FACS analysis of recipient PerC populations since, as we show next, Ly-1  B 
frequencies are normally quite high in these populations. 
Ly-1  B  Represent  a  Major  Proportion  of Peritoneal  B  Cells  in  Normal Ani- 
mals.  One-third to one-half of the IgM-bearing PerC are typical Ly-1  B cells 
that express relatively large amounts of IgM, small amounts of IgD, and small 
amounts  of  Ly-1.  Thus,  PerC  Ly-1  B  are  recognizable  either  as  a  clearly 
delineated population  of dull  IgD,  bright  IgM  cells in  IgM/IgD  FACS  plots, 
or as a relatively well-delineated population of dull Ly-1, bright IgM cells in Ly- 
1/IgM  plots  (Fig.  2).  Data  from three-color immunofluorescence studies (not 
shown) confirm that these individual analytic populations reflect different prop- 
erties of the same (Ly-1  B) cells. 
The other B cells in the peritoneum are, on the whole, similar in their IgM/ 
IgD expression to the predominant B cells in lymph node and spleen, and do not 
carry Ly-1. Thus, they are well resolved in the IgM/IgD contour plot as a bright 
IgD, dull IgM population, and reside in the Ly-l-, dull IgM region of the Ly-1/ 
IgM contour plot (see Fig. 2). Given the lack of anatomical organization of the 
apparently free-living lymphocytes in the peritoneum, the relative frequencies of 
these  two  PerC  populations  are surprisingly  constant  in  most  normal  mouse 
strains. 
Bone  Marrow  and  Spleen  Cells from  Adults  Selectively  Reconstitute  Ly-1-  B 
Cells.  In addition to reconstituting the major B cell populations in spleen and 
lymph nodes, adult bone marrow transfers selectively reconstitute the peritoneal 
B cells that display the predominant lymph node or splenic B cell phenotype (Ly- 
1-, bright IgD, dull IgM). As Fig.  3 shows, there are essentially no donor-type 
Ly-1  B  in  PerC  harvested  from  marrow-reconstituted recipients  2  mo  after 
transfer.  Nevertheless, Ly-1- PerC  B cells are clearly reconstituted to normal 
levels by this time. 
The B cell progenitors in spleen are very similar to the progenitors in bone 
marrow in that they reconstitute most B cells in irradiated recipients, but do not 
reconstitute Ly-1 B (see Table I). Thus, even though Ly-1 B make up 1% of the 
cells in spleen, animals that received 107 aIlotype congenic spleen ceils do not 
have detectable numbers of Ly-1  B in the peritoneal cavity 1 mo after transfer. 
Peritoneal  CeUs  from Adults Selectively Reconstitute Ly-1 B.  In contrast to bone 
marrow, transfers of PerC from normal adult (allotype congenic) donors fully 
reconstituted recipient PerC Ly-1  B populations.  11  d  after transfer, recipients 
showed low but detectable numbers of peritoneal Ly-1 B marked with the donor 
allotype  (data  not  shown).  Over  the  next  2  wk,  the  frequency and  absolute 
number  of these  donor-derived  cells  increased  >10-fold.  Thus,  1  mo  after 
transfer, PerC recipients had roughly normal numbers of donor-type Ly-1  B in 
peritonea (Fig. 3). 
These PerC transfers did not reconstitute the PerC B cells reconstituted by 1558  Ly-1  B  PROGENITORS 
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FZCORE 2.  Lyol B frequencies are higher in peritoneum than in spleen. Spleen and peritoneal 
cells (PerC) from  3-mo-old BAB/14 mice were simultaneously stained with fluoresceinated 
anti-lgh6b and biotinylated anti-lgh5b (top) or fluoresceinated anti-Igh6b and biotinylated 
anti-Ly-I (bottom).  PerC lgM/IgD analysis revealed a relatively large population of cells that 
have high levels of surface IgM (Igh-6b) and low levels of IgD (Igh-5b). IgM/Ly-1 analysis 
showed that most of these cells express low levels of Ly- 1. Ly- 1 B cell frequency in spleen (1%) 
is often too low to visualize on this type of contour plot. 
bone  marrow  transfers;  however, they did  reconstitute a  minor  PerC  B  cell 
population  that has the same IgM/IgD phenotype as Ly-1  B (dull IgD, bright 
IgM) while lacking Ly-1.  PerC-reconstituted recipients therefore have at  least 
two kinds of B cells (Ly-1  B and this second population), even though they lack 
the Ly-l- bright  IgD,  dull  IgM  B  cells that predominate in  lymph node and 
spleen. 
Liver,  Spleen,  and  Bone  Marrow  Cells  from  Young  Mice  Reconstitute  All  B 
Cells.  The physical segregation of cells that reconstitute Ly-1 B from cells that 
reconstitute other B cell populations occurs relatively late in postnatal life (Table 
I). Liver and spleen from neonatal animals (1-7 d old) still contain both kinds of 
progenitor cells. Similarly, bone marrow taken from animals as much as 3  wk 
old can reconstitute a sizable proportion of Ly-I B cells in addition to the typical HAYAKAWA ET  AL.  1559 
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FIGURE 3.  Adult PerC and adult bone marrow reconstitute  different B cell populations in 
irradiated recipients.  107 bone marrow cells (BM) or 107 PerC from 12-wk-old  adult BAB/14 
(Igh b) mice were transferred to 600-rad  irradiated  BALB/c (Igh') mice. 1 mo after transfer, 
PerC were analyzed for donor-derived (Igh  h) B cells. The boxes in the figure show the analytic 
gates used to determine the frequencies of Ly-I B and Ly-l- B.  Ly-1 B frequencies were 
corrected for background  staining by subtracting  the frequency of anti-Lyt-2-stained  cells 
that fell within the Ly-I B gates (usually 1-2% of total cells). In the experiments shown, the 
bone marrow-reconstituted animals had -1% Ly-1- B and 40% Ly-1- B, while the PerC- 
reconstituted animals had 20% Ly-1 B and 30% Ly-1- B, nearly all of which showed a surface 
phenotype (high IgM, low lgD) that is rare among normal splenic or peritoneal B cells. 
B  cells  reconstituted  by adult  bone  marrow.  We  have not  determined  exactly 
when bone marrow completely loses the ability to reconstitute  sizable numbers 
of Ly-1  B; however,  this capability tends  to be reduced  by 4  wk and  is clearly 
gone by 1 2  wk of age. 
Joint Transfers of PerC and Bone Marrow Cells from Adults Reconstitute  All B 
Cells.  Transferring bone  marrow cells from Igh  a donors and  PerC from con- 
genic Igh  b donors creates chimeric animals that have all of the FACS-detectable 
B  cell populations present  in normal  (nonirradiated)  mice.  The  Ly-1  B  cells in 
these animals express Igh  b ailotypes, and thus derive solely from the transferred 
PerC.  The  Ly-1-  B  cells,  in  contrast,  express  Igh  a aliotypes,  and  thus  derive 
mostly from the transferred bone marrow cells (see the FACS plots for recipient 
PerC in Fig. 4). Thus, neither of the progenitor sources blocks the development 
of progenitors  supplied  by the  other,  and  neither  source induces  the  other  to 
give rise to a broader spectrum of B cell subpopulations than it gives rise to when 
transferred individually. 
Joint  transfers  of bone  marrow  and  allotype-congenic  neonatal  liver  yield 
similar results in that Ly-1 B reconstitution proceeds normally, and the reconsti- 
tuted Ly-1 B cells derive solely from the neonatal liver donor. Since bone marrow 1560  Ly-1  B  PROGENITORS 
TABLE  I 
Ly-1 B Are Reconstituted by Newborn Liver, Newborn Spleen, Weanling Bone Marrow, and 
Adult Peritoneal Cells 
Cells injected*  Donor-derived B cells present in recipient 
peritoneum * 
Number  Mice 
Source  Donor age  (X 106)  All IgM  ÷  LY-1 B  tested 
%  % 
Liver  l-7 d  10  43 -+ 6  8 -+ 2  4 
Spleen  1-7 d  10  49 + 7  7 -  1  5 
Bone marrow  3 wk  10  43 -  13  6 + 2  5 
Peritoneum  12 wk  10  50 -+ 5  20 + 4  5 
4  26, 28  9, 12  2 
1  16---4  5--.2  3 
Spleen  12 wk  10  17 -+ 7  1 +  1  3 
Bone marrow  12 wk  10  39 + 21  1 -Z-- 1  8 
* Cells from BAB/14 (Igh  b) donor were injected intravenously to 600 rad-irradiated BALB/c (Igh  a) 
recipients. 
Frequencies were determined by FACS analysis of recipient  PerC  1 mo after transfer.  Donor- 
derived  B cells were identified  by staining with monoclonal antibodies  to donor IgM and IgD 
allotypes. No recipient-derived B cells were detected (< 1%) in any group of mice. 
and neonatal  liver both contain progenitors for Ly-1- B cells, about half of the 
Ly-1- B cells in these recipients express the allotype of the bone marrow donor, 
while the remainder express the allotype of the neonatal liver donor; all Ly-1  B 
cells,  in  contrast,  express  the  allotype  of the  neonatal  liver  donor  (data  not 
shown). 
These  findings  demonstrate  that  conditions  in  irradiated  recipients  of bone 
marrow allow Ly-1  B reconstitution to proceed normally, regardless of whether 
the Ly-1 B progenitors are drawn from mature or immature animals, or whether 
they  come  from  locations  that  potentially  differ  with  respect  to  the  average 
maturity  of the  B  cells present.  Thus,  the  failure  to  reconstitute  Ly-1  B  with 
bone marrow cells is the  result of a  functional  deficit of Ly-1  B  progenitors  in 
bone marrow from normal mice. 
Ly-I B  Are More Radioresistant  Than Other B  Cells.  In keeping with previous 
evidence (13, 25), our studies show that most splenic and lymph node B cells are 
highly sensitive to radiation.  Ly-1 B, however, tend to persist, and thus make up 
a  relatively large percentage of the surviving splenic B cells 7 d  after irradiation 
(600 rad in BALB/c); e.g., host-type Ly-1 B made up 20-30%  of the B cells in a 
spleen that had decreased ~300-fold in cellularity at this time (data not shown). 
Analysis of peritoneal cells in the irradiated animals demonstrates this relative 
radioresistance  of  Ly-1  B  even  more  clearly.  7  d  after  irradiation,  all  of the 
surviving peritoneal  B  cells showed the bright  IgM, dull  IgD phenotype of the 
Ly-1  B  population,  and  at  least  half express  Ly-1.  Similarly,  host-type  Ly-1  B 
were usually detectable in PerC harvested from irradiated animals reconstituted 
with allotype-congenic bone marrow cells, particularly when assayed within 2 wk 
of transfer (data not shown). HAYAKAWA  ET  AL.  1561 
Transferred  Cel Is  Reconstituted  BALB/C PerC  B Cell  Derivation 
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FIGURE 4.  Combined transfers of bone marrow (BM) and PerC fully reconstitute PerC B 
cells. 5 ×  106 adult bone marrow from BALB/c (Igh  a) donors were transferred with or without 
5 ×  106 PerC from BAB/14 (Igh  b) donors to 600-tad irradiated BALB/c recipients. Data show 
the IgM/Ly-I distribution of all PerC in recipients. The frequency of PerC (BAB/I 4)-derived 
B  cells was determined by staining with anti-lgh-6b and anti-Ly-l. The frequency of bone 
marrow-derived (BALB/c) B cells was determined by subtracting the frequency of Igh-6b- 
bearing B cells from the total |gM  + B cell frequency. 
Reconstitution  of  Splenic  Ly-1  B  Parallels  the  Reconstitution  of PerC  Ly-1 
B.  Complementary data from FACS and functional studies show that splenic 
Ly-1 B are reconstituted by PerC and tend to survive irradiation much as PerC 
Ly-1  B do (see Fig. 5 and Table II).  1 mo after transfer,  FACS analysis clearly 
shows donor-derived Ly-1 B in spleens from irradiated Igh  j CBA/N mice recon- 
stituted  with  PerC  from  allotype-congenic  CBA-Igh  b  mice  (Fig,  5).  Similar 
analysis revealed Ly-1 B populations at lower frequencies !n spleens from BALB 
and CBA mice reconstituted with allotype-congenic PerC (data not shown). Thus, 
cells recovered from the donor peritoneum are capable of reconstituting splenic 
Ly-1 B, in addition to reconstituting the peritoneal Ly-1 B populations discussed 
earlier. 
Data from functional studies independently confirm this conclusion. Virtually 
all  of  the  spleen  cells  that  produce  IgM  autoantibodies  to  BrMRBC  (anti- 
BrMRBC)  are  Ly-1  B  cells (11).  The activity  of these  cells is detectable  in a 
hemolytic  PFC  assay  modified  to  allow  determination  of  the  IgM  allotype 
produced by individual PFC, i.e., by inclusion of monoclonal anti-IgM allotype 
antibodies that specifically block PFC formation (Table II). This assay therefore 
provides a highly sensitive probe for detecting the presence of Ly-1 B in transfer 
recipients, and a direct method for determining the origin (allotype) of the PFC 
detected. 1562 
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FZGVRE 5.  Adult PerC reconstitute Ly-1 B in CBA/N spleen. 10  v  adult PerC or bone marrow 
(BM) cells from CBA-Igh donors were  transferred to irradiated CBA/N mice.  1 mo after 
transfer, PerC-reconstituted spleen showed 20% donor-derived B cells (10% Ly-1 B and 10% 
Ly-1- B), and 30% host-type B cells (<1% Ly-i B and 30% Ly-1- B). 
TABLE  II 
Anti-BrMRBC PFC (Ly-1 B) Are Reconstituted  by PerC But Not by Bone Marrow 
Allotype congenic ceils  Anti-BrMRBC PFC 
transferred*  per 10  s spleen* 
Strain  Irradiated 
Donor-  Source  Strain  Total  derived 
BALB/c  Yes  Bone marrow  BAB/14  30  <3 
BALB/c  Yes"  PerC  BAB/14  300  280 
CBA/N  Yes  PerC  CBA-Igh  b  150  150 
* 10  ~ cells were transferred intravenously to 600 rad-irradiated recipients.  BALB/c recipients  are 
lgha; CBA/N recipients are Igb  i. Donors are all Igh  b. 
* Spleens from reconstituted mice were analyzed  1 mo after transfer.  Three mice per group were 
tested; average values are shown. Spleens from normal BALB/c and BAB/14 controls yielded  15 
PFC/106 cells in this assay; CBA/N had no detectable  PFC. 
Donor-derived  (Igh b) PFC were identified by inhibition with monoclonal anti Igh-6b antibodies. 
This antibody inhibits all BAB/] 4 PFC and does not inhibit any BALB/c or CBA PFC. 
The ability to determine PFC allotype is particularly crucial for these studies, 
since radioresistant (host derived) anti-BrMRBC PFC are found in spleens in all 
recipients that show anti-BrMRBC PFC activity before irradiation, i.e., in essen- 
tially all mice except CBA/N. Donor-derived PFC, in contrast, are only detectable 
in  spleens from  PerC  recipients and are  clearly lacking in recipients of adult HAYAKAWA  ET  AL.  1563 
bone marrow (Table II). Thus, these highly sensitive functional studies confirm 
conclusions from FACS studies demonstrating that PerC transfers reconstitute 
Ly-1 B, whereas adult bone marrow transfers do not. 
Persistence of Transferred Ly-1 B  Cells Does Not Account for Ly-1 B  Reconstitu- 
tion.  Since host-derived Ly-1 B tend to persist for relatively long periods after 
irradiation, there is reason to suspect that at least some of the donor-derived Ly- 
1  B  found in  reconstituted recipients represent transferred Ly-1  B  cells that 
merely persist in  the new host.  The potential persistence of such cells cannot 
account for Ly-1 B reconstitution in recipients of neonatal liver or spleen, since 
too few Ig-bearing cells (including Ly-1  B) are present in the donor organs to 
account for the number of Ly-1  B  present  when reconstitution  is  complete. 
Therefore, Ly-1 B reconstitution from neonatal sources must involve the expan- 
sion and differentiation of immature progenitor cells that probably do not express 
surface Ig until sometime after transfer. 
Ly-1  B  reconstitution  from  adult  PerC,  in  contrast,  could  potentially  be 
explained by the persistence of fully mature Ly-1  B in the inoculum, since the 
estimated number of donor-derived Ly-1 B in fully reconstituted PerC recipients 
(1-2 mo after transfer) is, at most, several-fold higher than the number of Ly-1 
B injected initially. However, if this hypothesis were correct, virtually all of the 
injected Ly-1 B cells would have to survive substantially longer than mature cells 
usually survive in adoptive recipients. Furthermore, virtually all of the injected 
Ly-1  B  would have to migrate initially to inaccessible locations and later find 
their way to the peritoneum and the spleen, since very few donor-derived Ly-1 
B are detectable in PerC recipients until several weeks after transfer. 
The failure to reconstitute Ly-1 B cell populations in recipients of spleen cells 
from adults also argues against a simple persistence hypothesis. If we assume that 
splenic Ly-1 B are equivalent to PerC Ly-1 B vis-a-vis persistence, then transfers 
of 107 spleen cells should reconstitute Ly-1  B about as well as transfers of 1-2 x 
106 PerC (since PerC Ly-1 B frequencies are -10-fold higher than splenic Ly-1 
B  frequencies).  2  x  10 6  transferred PerC,  however, reconstituted substantial 
numbers of Ly-1  B, whereas spleen cells did not detectably reconstitute Ly-1  B 
in recipients (Table I). The persistence of Ly-1  B in recipients, therefore, does 
not appear sufficient to account for the Ly-1 B reconstitution by PerC. 
Curiously, preliminary evidence from FACS sorting and transfer experiments 
suggests that Ly-1 B are derived from Ig-bearing cells in PerC (K. Hayakawa, R. 
R. Hardy, and L. A. Herzenberg, unpublished data). Thus, since the evidence 
discussed above indicates that Ly-1 B reconstitution is not due to the persistence 
of mature  transferred  cells,  the  reconstituted  Ly-1  B  population  apparently 
derives from a small number of relatively mature (Ig-bearing) progenitors that 
still retain the potential for long-term self-renewal. 
Discussion 
The simplest and most straightforward way to interpret the cell transfer data 
presented here is to define two independent B cell lineages whose progenitors 
inhabit different sites in adult animals (Fig.  6).  The first lineage culminates in 
the predominant B cell populations in spleen and lymph nodes, and derives from 
classical B  cell progenitors that are present in  neonatal and adult spleen and 1564  Ly-1  B PROGENITORS 
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FIGURE 6.  Progenitors for Ly-1 B diverge before animals reach adulthood. This figure 
presents a tentative interpretation of the current B cell lineage data. The decision to draw two 
independent lineages (Ly-1 B and other B) is based on data presented here, indicating that 
these lineages exist, and that their progenitors have already diverged and are present in 
different locations (peritoneum vs. bone marrow) in animals >6 wk of age. The decision to 
include a tentative split in the "other" B cell lineage is based on previously  published evidence 
(7, 8). 
bone marrow, but are missing from adult PerC suspensions. The second lineage, 
in  contrast,  derives  from  previously unrecognized  B  cell  progenitors  that are 
present in adult PerC  suspensions and neonatal hematopoietic organs, but are 
missing from adult spleen and bone marrow.  This novel lineage culminates in 
the Ly-l-bearing B cell (Ly-1 B) populations in spleen (9) and peritoneum (10) 
that produce many of the commonly studied IgM autoantibodies found in normal 
and autoimmune mice (11). 
This  construct  is  based  on  analytical  (FACS)  and  functional  studies  of the 
progeny of individually and jointly transferred cell populations. The individual 
transfers showed that (a) adult PerC selectively reconstitute Ly-1 B in irradiated 
recipients; (b) adult bone marrow selectively reconstitutes other B cells; and (c) 
spleen,  liver, and bone marrow from very young animals reconstitute both the 
Ly-1  B  population and the other  (Ly-1-) B  cell populations.  In addition, joint 
transfer studies (adult bone  marrow  with either neonatal liver or adult  PerC) 
showed  that  each  progenitor  source  reconstitutes  all  of  the  B  cells  that  it 
reconstitutes when transferred alone. 
These findings largely rule out the presence of cryptic Ly-1 B progenitors in 
bone  marrow:  first,  bone  marrow  does  not  block  Ly-1  B  development  when 
appropriate progenitors are present (from PerC or neonatal liver donors); second, 
although  both  PerC  and  neonatal  liver  give  rise  to  Ly-1  B,  neither  of these 
sources supports  the  development of Ly-1  B  from  cotransferred,  allotypically 
distinguished bone marrow cells. Similarly, these findings (not surprisingly) rule 
out the presence  of bone marrow-type B  cell progenitors  in  PelC.  Thus  they 
provide  a  strong base  for concluding that  Ly-1  B  do not belong to  the  same 
lineage as the predominant splenic  and lymph node B  ceil populations (whose 
progenitors are clearly detectable in bone marrow in adults). 
Previous suggestions (7) of lineage differences among B cells do not pertain to 
this  Ly-1  B  lineage  distinction.  In  essence,  these  earlier  studies  focused  on 
genetically controlled differences in  the predominant  B  cell populations.  The 
evidence they generated can now be interpreted as indicating that bone marrow- 
derived  (Ly-1-)  B  cells  are  further  subdivided  into  two  lineages,  one  that HAYAKAWA ET AL.  1565 
predominates in  nude mice, and the other in  X-linked immunodefective (xid) 
animals (7).  We show these putative lineages in the summary diagram in Fig. 6; 
however, we consider their existence tentative, since evidence from progenitor 
studies such as those presented here is still lacking. 
The developmental stage at which the Ly-1 B lineage diverges from other B 
cell  lineage(s)  has  yet to  be  determined.  Although  these  lineages are  clearly 
derived from different progenitors in adults, they quite possibly may be derived 
from a  common progenitor  in  immature animals (since progenitors  for both 
lineages are found in spleen, liver, and bone marrow from neonatal and weanling 
animals). Alternatively, they may be derived from progenitors that are already 
distinct in immature animals but do not migrate to unique sites until relatively 
late in development. In either case, these lineages must ultimately be traceable 
to a  single progenitor, since (by definition) all lineages bifurcate at some point 
during fetal or neonatal development. 
If Ly-1 B progenitors are already distinct from other B cell progenitors in fetal 
and neonatal  organs,  then,  ironically, current concepts of pre-B cells may be 
based largely on the behavior of cells drawn from the Ly-1  B lineage. Much of 
our understanding of B cell development derives from studies with pre-B and B 
cell lines, and tumors such as 70Z (26),  BCL1  (27), CH1  (28), and NFS-5 (29), 
all of which carry Ly-1  surface molecules (R.  Hardy, K.  Hayakawa, and L. A. 
Herzenberg, unpublished observations).  Furthermore, much of what is known 
about the properties of normal (nonmalignant) pre-B cells derives from studies 
of cell populations  from immature (fetal and neonatal) animals, and thus may 
mainly reflect the properties of Ly-1  B progenitors (since Ly-1  B cells represent 
such a large proportion of neonatal B cells) (9). Although spleen, liver, and bone 
marrow from young animals contain progenitors that reconstitute all  B  cells, 
studies  of pre-B  cells  derived from  adult  bone  marrow  may be  required  to 
unambiguously characterize the progenitors of the majority of the B cells found 
in adults. 
These considerations may be key to understanding recently reported differ- 
ences in  the properties of pre-B cells derived from different sources (30-33). 
The  IgH  gene rearrangements that  occur in  viraily induced (Abelson) pre-B 
tumors derived from adult  bone  marrow  differ, for example,  from the  IgH 
rearrangements that  occur in  similarly  induced pre-B  tumors  from  neonatal 
animals (33).  These differences may be due to differences in the properties of 
immature vs.  mature  B  cell  progenitors;  however,  they may equally well  be 
ascribable to basic biological differences that distinguish Ly-1 B progenitors from 
the progenitors of other B cells. 
Similarly, evidence demonstrating that hybridoma fusions with fetal and neo- 
natal B cells tend to yield more self-reactive antibodies than fusions with B cells 
from adults probably reflects the larger proportion of Ly-1 B cells in neonates 
(since Ly-1  B are known to be enriched for autoantibody-producing cells).  The 
recovery of a  relatively large  number of hybridomas producing antiidiotypic 
antibodies from the neonatal mice is particularly noteworthy since (what appear 
to be) Ly-1  B cells in adults have been implicated in the regulation of allotype 
(34)  and  idiotype (35)  expression in  antibody responses.  Perhaps  the  Ly-1  B 
lineage is specifically charged with a regulatory role that includes the production 1566  Ly-1  B  PROGENITORS 
ofautoantibodies active in regulatory networks, such as those proposed originally 
by Jerne (36). 
Summary 
Data from previous multiparameter fluorescence-activated cell sorter (FACS) 
analysis and sorting studies define a subset of murine B cells that expresses the 
Ly-1 surface determinant in conjunction with IgM, IgD, Ia, and other typical B 
cell markers. These Ly-1  B cells are physically and functionally distinct. They 
express more IgM and less IgD than most other B cells;  they are not normally 
found in lymph node or bone marrow; they are always present at low frequencies 
(1-5%) in normal spleens, and, as we show here, they comprise about half of the 
B cells  (10-20%  of total cells)  recovered from the peritoneal cavity in normal 
mice. Furthermore, most of the commonly studied IgM autoantibodies in normal 
and autoimmune mice are  produced by these Ly-1  B cells,  even though they 
seldom produce antibodies to exogenous antigens such as trinitrophenyI-Ficoll 
or trinitrophenyl-keyhole limpet hemocyanin. 
Cell transfer studies presented here demonstrate that the progenitors of Ly-1 
B cells are different from the progenitors of the predominant B cell populations 
in spleen and lymph node. In these studies, we used FACS analysis and functional 
assays to characterize donor-derived (allotype-marked) B cells present in lethally 
irradiated recipients 1-2 mo after transfer. Surprisingly, adult bone marrow cells 
typically used to reconstitute B cells in irradiated recipients selectively failed to 
reconstitute the Ly-1 B subset. Liver, spleen, and bone marrow cells from young 
mice,  in  contrast,  reconstituted all  B  cells  (including Ly-1  B),  and peritoneal 
"washout" cells  (PerC)  from adult mice  uniquely reconstituted Ly-1  B.  Bone 
marrow did not block Ly-1 B development, since PerC and newborn liver still 
gave  rise  to  Ly-1  B  when jointly  transferred  with  marrow.  These  findings 
tentatively assign  Ly-1  B  to a  distinct developmental lineage originating from 
progenitors that inhabit the same locations as other B cell progenitors in young 
animals, but move to unique location(s) in adults. 
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